Return to Conference Proceedings Submission Details
52-WEEK EFFICACY AND SAFETY OF BARISITINIB PLUS METHOTREXATE VERSUS METHOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A REAL-WORLD COHORT STUDY
Download
Download PDF